Gram-positive anaerobic cocci (GPAC) are a heterogeneous group of organisms that are isolated from clinical specimens more often than any group of anaerobic bacteria except Bacteroides species, yet many strains are still difficult or impossible to identify in the diagnostic laboratory. In this study, a total of 124 strains including 13 reference strains of GPAC species and 111 isolates that were previously recovered from clinical specimens and identified by 16S rRNA gene sequencing, were subjected to biochemical characterization. Based on the results, a short biochemical scheme that involves the minimum essential biochemical tests for accurate identification of clinically important GPAC was developed.
Gram-positive anaerobic cocci (GPAC) are a heterogeneous group of organisms that form part of the normal endogenous flora of humans. They are isolated from clinical specimens more often than any group of anaerobic bacteria except Bacteroides species, yet many strains are still difficult or impossible to identify in the diagnostic laboratory (2, 4, 5) . As a result, very little work has been done on the clinical importance of individual species of GPAC. The classification of the GPAC is not sound and has been confused by many loosely defined taxa. Peptoniphilus asaccharolyticus and Anaerococcus prevotii, the two butyrate-producing species commonly reported from human pathological material, have long been recognized as genetically heterogeneous (5) .
In a previous study (10), we evaluated 16S rRNA gene sequencing as a tool for accurate identification of GPAC and noted the problems with sequences for GPAC present in a public database that may not be evident to all users and would lead to misidentification. While 16S rRNA gene sequencing provides a powerful and reliable identification protocol for GPAC, it is not yet standardized and feasible for many clinical laboratories. Most clinical laboratories still rely on identification based on phenotypic tests or, more commonly, do not even attempt speciation. For routine identification of clinical isolates, ease of testing and total time required for completion are important. It has been shown that the GPAC species can be discriminated by routine phenotypic methods when supported by molecular data (7). In this study, to clarify the key features for identification of the recognized species of GPAC, and to detect groups of strains that might constitute undescribed species, we have studied a collection of clinical strains of GPAC and compared them with a reference collection that included most of the 3
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on October 21, 2017 by guest http://jcm.asm.org/ Downloaded from 22 recognized type strains of GPAC. Using 16S rDNA sequencing as a standard, we developed a biochemical scheme for accurate identification of this group of bacteria.
Materials and Methods:
Bacterial strains and culture conditions
The bacterial strains used in this study included 13 GPAC reference strains and 111 isolates that were previously recovered from clinical specimens and identified by 16S rRNA gene sequencing in our previous study ( Table 1 ). The breakdown of 111 clinical strains by 16S rRNA gene sequencing was as follows: 95 strains had a sequence with a relatively high similarity ( 98.0 %) to the type strains of an established species. The other 16 srains represent newly recognized taxa which, for the present, are placed in groups I, II and III. Six strains (group I) shared a sequence similarity of 97.2% with the type strain of Peptoniphilus harei. Four strains (group II) shared a relatively high sequence similarity (97.2 %) with P. asaccharolyticus strain GIFU 7717 (GenBank accession #: D14145), but very low sequence similarity (<90%) with P. asaccharolyticus type strain CCUG 9988, again, the most closely related type strain is P. harei (93% sequence similarity). Six strains (group III) had a sequence similar to that of an uncultured clostridium bacterial clone from human wounds (GenBank access # DQ169836) and its most closely related described species was Anaerococcus lactolyticus (approximate 96.5% sequence similarity). All strains were cultured overnight on Brucella blood agar (Anaerobe Systems, Morgan Hill, CA) at 37 C under N 2 (86%), H 2 (7%), and CO 2 (7%) gas phase. 
Results

:
Key phenotypic characteristics to differentiate GPAC A total of 124 strains including 13 reference strain and 111 clinical isolates, which were identified based on approximately full length (1400bp) of the16S rRNA gene sequence analysis in our previous study (10), were subjected to phenotypic characterization. Table 2 Tests indicated in the flow chart often gave strong reactions; other tests not indicated in the flow chart but in Table 2 can be used for confirmation, if needed. an enzyme profile similar to that of P. lacrimalis, however, organisms in group I can be differentiated from P. lacrimalis and strains of group II by producing glutamyl glutamic acid arylamidase, but not alanine arylamidase, in contrast to P. lacrimalis and group II.
Peptostreptococcus anaerobius and
Organisms of group II can be distinguished from P. lacrimalis by being alkaline phosphatase-positive. Strains of P. asaccharolyticus produce an enzyme profile very similar to that of strains of P. harei. The results we obtained from three P. asaccharolyticus strains we tested indicated that they can be readily distinguished from P. harei by being alkaline phosphatase-positive (Table 2& Fig.1 ).
Among the saccharolytic GPAC strains, Anaerococcus vaginalis and A. lactolyticus can be differentiated from Anaerococcus octavius and Anaerococcus hydrogenalis by producing arginine arylamidase and leucine arylamidase, while A. octavius and A. hydrogenalis do not, and they can be readily differentiated from each other by features such as urease and -galactosidase (Table 2) . Again, we recognized a group of saccharolytic GPAC strains (group III) which has a proteolytic enzyme profile very similar to that of A. lactolyticus, but it can be readily differentiated from A. lactolyticus by being urease-negative. A. hydrogenalis can be differentiated from A.
octavius by producing -glucosidase and indole, but not proline arylamidase (Table 2& Fig .1 ).
Metabolic endproducts of glucose metabolism.
Gram-positive anaerobic cocci are separated into five groups based on fatty acid end-products of metabolism analyzed by gas-liquid chromatography (GLC) (see Table 2 2) a butyrate-acetate (Ba) group that produces butyric acid as its major terminal volatile fatty acid (VFA), and acetic acid as a second acid; this group contains all of the species in the genus Anaerococcus; 3) an acetate-butyrate (Ab) group that produces acetic acid as its major terminal VFA, and butyric acid as the second acid; this group contains all of the species in the genus Peptoniphilus; except for P. ivorii; 4) a caproate (C) group whose members produce large quantities of longer-chain VFAs. The most important species in this last group is P. anaerobius, the only species of gram-positive anaerobic cocci to produce a major terminal peak of isocaproic acid; 5) an isovaleric acid (IV) group that contains P. ivorii--the only species of gram-positive anaerobic cocci that produces a major terminal peak of isovaleric acid. GLC is also useful for identifying the rarely isolated Peptococcus niger and P. octavius, which produce n-caproic acid.
Discussion
GPAC are a major part of the normal human flora and are frequently recovered from human clinical material; they constituted 24 to 31% of all isolates in four surveys of anaerobic pathogens (1, 3, 6, 12) . However, studies of the significance of isolates of GPAC have been hindered by an inadequate classification and the lack of a valid identification scheme. For example, P. asaccharolyticus is a gram-positive anaerobic coccal species frequently isolated from human clinical specimens, but strains that are identified phenotypically are genetically diverse. To complicate matters further, the type strain of P. asaccharolyticus is highly atypical in its whole-cell composition (8) and some biochemical properties (7). Our previous study (10) based on 16S rRNA gene sequence analysis indicated that most of strains that were identified as P. asaccharolyticus phenotypically only shared a low sequence similarity (<90%) with the corresponding (GenBank accession #: AY 244779), and the most phylogenetically related type strain is that of P. harei (approximately 98.6% sequence similarity). Although there is no an accepted cutoff value of 16S rRNA sequence similarity for species definition, it is apparent from the results of studies of numerous diverse taxa that the majority of recognized species that have been examined to date differ in their 16S rRNA sequence from related species of the same genus in at least 1 % of the sequence positions, and typically more. In this study, we identified this group of so-called P. asaccharolyticus isolates as P. harei because of the relatively high sequence similarity (98.6%) and very similar phenotypic characteristics between them. Further study involving DNA-DNA hybridization is being carried out to determine whether this group of bacteria merits a novel species or a subspecies of P. harei. previously for P. harei strains; colonies of 5-day cultures on enriched blood agar are approximately 1 mm in diameter, entire, flat translucent. However, the other type is the same as described previously for P. asaccharolyticus strains; colonies are convex, circular, entire, opaque, 2-3 mm with a distinctive lemon-yellow tinge and a central peak.
Therefore, we concluded that colony morphology is not a good criterion for differentiation between P. harei and P. asaccharolyticus. Our data indicated that the alkaline phosphatase test might be useful to differentiate the two species; however, more strains of P. asaccharolyticus need to be tested. It has been shown that the GPAC species, as supported by the molecular data, can be discriminated by routine phenotypic methods. However, there has not been much effort made, to our knowledge, to devise a phenotypic scheme that would be effective and relatively rapid for identification of GPAC. Murdoch summarized the differential characteristics of the GPAC including the newly described species, based on volatile fatty Most identification schemes have used indole production as a key test for the differentiation of butyrate-producing GPAC. For example, until recently, all butyrateproducing GPAC that formed indole were identified as P. asaccharolyticus; thus, indolenegative strains of P. asaccharolyticus presented a problem. It has long been accepted that most species of GPAC are strongly proteolytic and use the products of protein or peptide decomposition as a major energy source. In this study, we attempted to apply mainly saccharolytic and proteolytic enzyme tests selectively and set up an accurate identification tree (flow chart) that is based on solid identification obtained from 16S rDNA sequencing, rather than doing all the phenotypic tests on all isolates. We were able to identify the key phenotypic tests for relatively rapid identification of GPAC, and our results show good agreement with the data summarized by Murdoch (5). However, for those species for which we had insufficient numbers of strains to test (P. asacchrolyticus,
P. lacrimalis, P. ivorii, A. hydrogenalis, A. lactolyticus, A. octavirus, and A. tetradius),
the distinctions cannot be generalized.
There is strong evidence that related species of clinical importance still await formal description. In this study, we found three groups of GPAC (groups I, II and III) that are phylogenetically and phenotypically distinct from the established GPAC species; they merit separate species status. We are proposing groups I, II and III as Peptoniphilus gorbachii sp. nov., Peptoniphilus olsenii sp. nov., and Anaerococcus murdochii sp. nov., respectively (11). Systematic description of new bacterial species recovered from patients may contribute to the description of emerging infections. Therefore efforts should be made to report novel species, even if only very few strains have been isolated.
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In conclusion, we developed a short biochemical scheme based on the solid identification we obtained from sequencing to provide clinical laboratories with an inexpensive and simple alternative for identification of GPAC. 1 SPS (Sodium Polyanethol Sulfonate) test was done using an SPS disk (Anaerobe Systems, Morgan Hill, CA). All gram-positive anaerobic cocci are resistant to SPS except for P. anaerobius and P. stomatis which show a zone of inhibition of 12mm around an SPS disk. P. micros also exhibits a zone of inhibition with SPS; however, the zone is usually <12 mm in size. R, no zone or zone of inhibition <12 mm; S, zone of inhibition is 12mm. 2 All the enzymatic tests were done using rapid ID 32A systems (API bioMérieux, Marcy l'Etoile, France), according to the manufacturer's instructions. -GLU, -glucosidase; -GAL, -galactosidase; GUR, ß-glucuronidase; ArgA, arginine arylamidase (AMD); GGA, glutamyl acid glutamique AMD; ProA, proline AMD; PyrA, pyroglutamyl AMD; SerA, serine AMD; AlkP, alkaline phosphatase 3 Glucose fermentation tests were performed using pre-reduced, anaerobically sterilized 3 SPS, sodium polyanethol sulfonate; R, no zone or zone of inhibition is <12 mm); S, zone of inhibition is 12mm 4 Glucose fermentation tests were performed using pre-reduced, anaerobically sterilized Peptone-Yeast-Glucose (PYG) broth tube (Anaerobe Systems, Morgan Hill, CA). A pH <5.5 in the PYG tubes was interpreted as positive and >5.9 as negative fermentation. 
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